Rutin Inhibits Neuroinflammation and Provides Neuroprotection in an Experimental Rat Model of Subarachnoid Hemorrhage, Possibly Through Suppressing the RAGE–NF-κB Inflammatory Signaling Pathway

Neurochemical Research

Volumn 41, Issue 6, 2016, Pages 1496-1504

  Hao, Guangzhi ^a   Dong, Yushu ^a   Huo, Rentao ^a   Wen, Kai ^a   Zhang, Yinsong ^a   Liang, Guobiao ^a  

^a GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

Neuroinflammation; NF B; RAGE; Rutin; Subarachnoid hemorrhage

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN; RUTOSIDE; WATER; AGER PROTEIN, RAT; AUTACOID;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL PERFORATION; BRAIN; BRAIN CORTEX; BRAIN EDEMA; BRAIN INJURY; BRAIN WATER; CELL DEATH; CONTROLLED STUDY; DRUG EFFICACY; DRUG INHIBITION; INFLAMMATION; MALE; MEMBRANE PERMEABILITY; NERVE CELL; NERVOUS SYSTEM INFLAMMATION; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; SHAM PROCEDURE; SIGNAL TRANSDUCTION; SUBARACHNOID HEMORRHAGE; ANIMAL; ANTAGONISTS AND INHIBITORS; DISEASE MODEL; DRUG EFFECTS; METABOLISM; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; ANIMALS; DISEASE MODELS, ANIMAL; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; NEUROPROTECTION; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; RUTIN; SIGNAL TRANSDUCTION; SUBARACHNOID HEMORRHAGE;

EID: 84957640233     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-016-1863-7     Document Type: Article

References (39)

1. van Gijn J, Kerr RS, Rinkel GJ (2007) Subarachnoid haemorrhage. Lancet 369(9558):306–318
2. Velat GJ, Kimball MM, Mocco JD, Hoh BL (2011) Vasospasm after aneurysmal subarachnoid hemorrhage: review of randomized controlled trials and meta-analyses in the literature. World Neurosurg 76(5):446–454
3. Cahill J, Zhang JH (2009) Subarachnoid hemorrhage: is it time for a new direction? Stroke 40(3 Suppl):S86–S87
4. Sehba FA, Hou J, Pluta RM, Zhang JH (2012) The importance of early brain injury after subarachnoid hemorrhage. Prog Neurobiol 97(1):14–37
5. Cahill J, Calvert JW, Zhang JH (2006) Mechanisms of early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab 26(11):1341–1353
6. Sozen T, Tsuchiyama R, Hasegawa Y, Suzuki H, Jadhav V, Nishizawa S et al (2009) Role of interleukin-1beta in early brain injury after subarachnoid hemorrhage in mice. Stroke 40(7):2519–2525
7. Yan SF, Yan SD, Ramasamy R, Schmidt AM (2009) Tempering the wrath of RAGE: an emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation. Ann Med 41(6):408–422
8. Ramasamy R, Yan SF, Schmidt AM (2009) RAGE: therapeutic target and biomarker of the inflammatory response–the evidence mounts. J Leukoc Biol 86(3):505–512
9. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A et al (1996) RAGE and amyloid-beta peptide neurotoxicity in Alzheimer’s disease. Nature 382(6593):685–691
10. Bianchi R, Giambanco I, Donato R (2010) S100B/RAGE-dependent activation of microglia via NF-kappaB and AP-1 Co-regulation of COX-2 expression by S100B, IL-1beta and TNF-alpha. Neurobiol Aging 31(4):665–677
11. Uivarosi V, Barbuceanu SF, Aldea V, Arama CC, Badea M, Olar R et al (2010) Synthesis, spectral and thermal studies of new rutin vanadyl complexes. Molecules 15(3):1578–1589
12. Isai M, Sakthivel M, Ramesh E, Thomas PA, Geraldine P (2009) Prevention of selenite-induced cataractogenesis by rutin in Wistar rats. Mol Vis 15:2570–2577
13. Sharma S, Ali A, Ali J, Sahni JK, Baboota S (2013) Rutin: therapeutic potential and recent advances in drug delivery. Expert Opin Investig Drugs 22(8):1063–1079
14. Khan MM, Ahmad A, Ishrat T, Khuwaja G, Srivastawa P, Khan MB et al (2009) Rutin protects the neural damage induced by transient focal ischemia in rats. Brain Res 1292:123–135
15. Jeong JJ, Ha YM, Jin YC, Lee EJ, Kim JS, Kim HJ et al (2009) Rutin from Lonicera japonica inhibits myocardial ischemia/reperfusion-induced apoptosis in vivo and protects H9c2 cells against hydrogen peroxide-mediated injury via ERK1/2 and PI3K/Akt signals in vitro. Food Chem Toxicol 47(7):1569–1576
16. Korkmaz A, Kolankaya D (2010) Protective effect of rutin on the ischemia/reperfusion induced damage in rat kidney. J Surg Res 164(2):309–315
17. Jang JW, Lee JK, Hur H, Kim TW, Joo SP, Piao MS (2014) Rutin improves functional outcome via reducing the elevated matrix metalloproteinase-9 level in a photothrombotic focal ischemic model of rats. J Neurol Sci 339(1–2):75–80
18. Rodrigues AM, dos Santos Marcilio F, Frazao Muzitano M, Giraldi-Guimaraes A (2013) Therapeutic potential of treatment with the flavonoid rutin after cortical focal ischemia in rats. Brain Res 1503:53–61
19. Nafees S, Rashid S, Ali N, Hasan SK, Sultana S (2015) Rutin ameliorates cyclophosphamide induced oxidative stress and inflammation in Wistar rats: role of NFkappaB/MAPK pathway. Chem Biol Interact 231:98–107
20. Yamaguchi M, Zhou C, Nanda A, Zhang JH (2004) Ras protein contributes to cerebral vasospasm in a canine double-hemorrhage model. Stroke 35(7):1750–1755
21. Uyama O, Okamura N, Yanase M, Narita M, Kawabata K, Sugita M (1988) Quantitative evaluation of vascular permeability in the gerbil brain after transient ischemia using Evans blue fluorescence. J Cereb Blood Flow Metab 8(2):282–284
22. You WC, Li W, Zhuang Z, Tang Y, Lu HC, Ji XJ et al (2012) Biphasic activation of nuclear factor-kappa B in experimental models of subarachnoid hemorrhage in vivo and in vitro. Mediators Inflamm 2012:786242
23. Zhuang Z, Zhou ML, You WC, Zhu L, Ma CY, Sun XJ et al (2012) Hydrogen-rich saline alleviates early brain injury via reducing oxidative stress and brain edema following experimental subarachnoid hemorrhage in rabbits. BMC Neurosci 13:47
24. Ostrowski RP, Colohan AR, Zhang JH (2005) Mechanisms of hyperbaric oxygen-induced neuroprotection in a rat model of subarachnoid hemorrhage. J Cereb Blood Flow Metab 25(5):554–571
25. Broderick JP, Brott TG, Duldner JE, Tomsick T, Leach A (1994) Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke 25(7):1342–1347
26. Ostrowski RP, Colohan AR, Zhang JH (2006) Molecular mechanisms of early brain injury after subarachnoid hemorrhage. Neurol Res 28(4):399–414
27. Sehba FA, Pluta RM, Zhang JH (2011) Metamorphosis of subarachnoid hemorrhage research: from delayed vasospasm to early brain injury. Mol Neurobiol 43(1):27–40
28. Church LD, Churchman SM, Hawkins PN, McDermott MF (2006) Hereditary auto-inflammatory disorders and biologics. Springer Semin Immunopathol 27(4):494–508
29. Lockyer JM, Colladay JS, Alperin-Lea WL, Hammond T, Buda AJ (1998) Inhibition of nuclear factor-kappaB-mediated adhesion molecule expression in human endothelial cells. Circ Res 82(3):314–320
30. Branen L, Hovgaard L, Nitulescu M, Bengtsson E, Nilsson J, Jovinge S (2004) Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 24(11):2137–2142
31. Takeda R, Suzuki E, Satonaka H, Oba S, Nishimatsu H, Omata M et al (2005) Blockade of endogenous cytokines mitigates neointimal formation in obese Zucker rats. Circulation 111(11):1398–1406
32. Arjumand W, Seth A, Sultana S (2011) Rutin attenuates cisplatin induced renal inflammation and apoptosis by reducing NFkappaB, TNF-alpha and caspase-3 expression in wistar rats. Food Chem Toxicol 49(9):2013–2021
33. Yeh CH, Yang JJ, Yang ML, Li YC, Kuan YH (2014) Rutin decreases lipopolysaccharide-induced acute lung injury via inhibition of oxidative stress and the MAPK-NF-kappaB pathway. Free Radic Biol Med 69:249–257
34. Annapurna A, Ansari MA, Manjunath PM (2013) Partial role of multiple pathways in infarct size limiting effect of quercetin and rutin against cerebral ischemia-reperfusion injury in rats. Eur Rev Med Pharmacol Sci 17(4):491–500
35. Qu J, Zhou Q, Du Y, Zhang W, Bai M, Zhang Z et al (2014) Rutin protects against cognitive deficits and brain damage in rats with chronic cerebral hypoperfusion. Br J Pharmacol 171(15):3702–3715
36. Lotze MT, Tracey KJ (2005) High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5(4):331–342
37. Hudson BI, Harja E, Moser B, Schmidt AM (2005) Soluble levels of receptor for advanced glycation endproducts (sRAGE) and coronary artery disease: the next C-reactive protein? Arterioscler Thromb Vasc Biol 25(5):879–882
38. Kalea AZ, Schmidt AM, Hudson BI (2009) RAGE: a novel biological and genetic marker for vascular disease. Clin Sci (Lond). 116(8):621–637
39. Li J, Schmidt AM (1997) Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products. J Biol Chem 272(26):16498–16506